Pharmacodynamics and pharmacokinetics of oral salmon calcitonin in the treatment of osteoporosis

The environment and disease: association or causation?

(2015) Austin Bradford Hill   JOURNAL OF THE ROYAL SOCIETY OF MEDICINE

Treatment of symptomatic knee osteoarthritis with oral salmon calcitonin: results from two phase 3 trials

(2015) M.A. Karsdal et al.   OSTEOARTHRITIS AND CARTILAGE

Does salmon calcitonin cause cancer? A review and meta-analysis

(2015) G. Wells et al.   OSTEOPOROSIS INTERNATIONAL

Salmon Calcitonin Use and Associated Cancer Risk

(2014) Robert A. Overman et al.   ANNALS OF PHARMACOTHERAPY

Oral salmon calcitonin enhances insulin action and glucose metabolism in diet-induced obese streptozotocin-diabetic rats

(2014) Michael Feigh et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Additive effect of elcatonin to risedronate for chronic back pain and quality of life in postmenopausal women with osteoporosis: a randomized controlled trial

(2014) Michio Hongo et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Osteoporosis Medication Use After Hip Fracture in U.S. Patients Between 2002 and 2011

(2014) Daniel H Solomon et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Calcitonin Nasal Spray and Increased Cancer Risk: A Population-Based Nested Case-Control Study

(2014) Li-Min Sun et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Efficacy and safety of oral recombinant calcitonin tablets in postmenopausal women with low bone mass and increased fracture risk: a randomized, placebo-controlled trial

(2014) N. Binkley et al.   OSTEOPOROSIS INTERNATIONAL

Trends in osteoporosis treatment with oral and intravenous bisphosphonates in the United States, 2002–2012

(2013) Diane K. Wysowski et al.   BONE

Prevention and treatment of postmenopausal osteoporosis

(2013) Sri Harsha Tella et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Oral salmon calcitonin protects against impaired fasting glycemia, glucose intolerance, and obesity induced by high-fat diet and ovariectomy in rats

(2013) Michael Feigh et al.   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

A review on strontium ranelate long-term antifracture efficacy in the treatment of postmenopausal osteoporosis

(2013) Luisella Cianferotti et al.   Therapeutic Advances in Musculoskeletal Disease

Elcatonin in Combination with Risedronate Is More Effective than Risedronate Alone for Relieving Back Pain in Postmenopausal Women with Osteoporosis

(2012) Masayuki Takakuwa et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: The oral calcitonin in postmenopausal osteoporosis (ORACAL) trial

(2012) Neil Binkley et al.   JOURNAL OF BONE AND MINERAL RESEARCH

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

(2012) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

Oral Calcitonin

(2012) Michael J. Maricic   Current Osteoporosis Reports

A novel oral form of salmon calcitonin improves glucose homeostasis and reduces body weight in diet-induced obese rats

(2011) M. Feigh et al.   DIABETES OBESITY & METABOLISM

Oral Salmon Calcitonin Improves Fasting and Postprandial Glycemic Control in Lean Healthy Rats

(2011) M. Feigh et al.   HORMONE AND METABOLIC RESEARCH

Calcitonin for treating acute and chronic pain of recent and remote osteoporotic vertebral compression fractures: a systematic review and meta-analysis

(2011) J. A. Knopp-Sihota et al.   OSTEOPOROSIS INTERNATIONAL

Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research

(2010) Elizabeth Shane et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Lessons Learned From the Development of Oral Calcitonin: The First Tablet Formulation of a Protein in Phase III Clinical Trials

(2010) M. A. Karsdal et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Investigations of inter- and intraindividual relationships between exposure to oral salmon calcitonin and a surrogate marker of pharmacodynamic efficacy

(2009) Morten A. Karsdal et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

A Pharmacokinetic and Pharmacodynamic Comparison of Synthetic and Recombinant Oral Salmon Calcitonin

(2009) Morten A. Karsdal et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Nasal Delivery of High Molecular Weight Drugs

(2009) Yıldız Ozsoy et al.   MOLECULES

The effect of oral salmon calcitonin delivered with 5-CNAC on bone and cartilage degradation in osteoarthritic patients: a 14-day randomized study

(2009) M.A. Karsdal et al.   OSTEOARTHRITIS AND CARTILAGE